ID   MARH6_HUMAN             Reviewed;         910 AA.
AC   O60337; A5PKZ4; B4DKJ2; B4DT33; D3DTC8; O14670; Q86X77;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 2.
DT   28-JUN-2023, entry version 169.
DE   RecName: Full=E3 ubiquitin-protein ligase MARCHF6;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:15673284, ECO:0000269|PubMed:24449766};
DE   AltName: Full=Doa10 homolog;
DE   AltName: Full=Membrane-associated RING finger protein 6;
DE   AltName: Full=Membrane-associated RING-CH protein VI;
DE            Short=MARCH-VI {ECO:0000303|PubMed:16373356};
DE   AltName: Full=Protein TEB-4 {ECO:0000303|PubMed:15673284, ECO:0000303|PubMed:16373356, ECO:0000303|PubMed:19651899};
DE   AltName: Full=RING finger protein 176;
DE   AltName: Full=RING-type E3 ubiquitin transferase MARCHF6 {ECO:0000305};
GN   Name=MARCHF6 {ECO:0000312|HGNC:HGNC:30550};
GN   Synonyms=KIAA0597, MARCH6, RNF176, TEB4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 379-910 (ISOFORM 1), AND VARIANT LEU-622.
RA   Simmons A.D., Lovett M.L.;
RT   "High resolution physical and transcription maps of the Cri-du-chat
RT   critical region.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   IDENTIFICATION.
RX   PubMed=11641273; DOI=10.1101/gad.933301;
RA   Swanson R., Locher M., Hochstrasser M.;
RT   "A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum
RT   that functions in both ER-associated and Matalpha2 repressor degradation.";
RL   Genes Dev. 15:2660-2674(2001).
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, TOPOLOGY,
RP   UBIQUITINATION, MUTAGENESIS OF CYS-9, DOMAIN, AND PATHWAY.
RX   PubMed=15673284; DOI=10.1042/bj20041241;
RA   Hassink G., Kikkert M., van Voorden S., Lee S.-J., Spaapen R., van Laar T.,
RA   Coleman C.S., Bartee E., Frueh K., Chau V., Wiertz E.;
RT   "TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the endoplasmic
RT   reticulum.";
RL   Biochem. J. 388:647-655(2005).
RN   [9]
RP   TOPOLOGY.
RX   PubMed=16373356; DOI=10.1074/jbc.m512215200;
RA   Kreft S.G., Wang L., Hochstrasser M.;
RT   "Membrane topology of the yeast endoplasmic reticulum-localized ubiquitin
RT   ligase Doa10 and comparison with its human ortholog TEB4 (MARCH-VI).";
RL   J. Biol. Chem. 281:4646-4653(2006).
RN   [10]
RP   FUNCTION AS AN E3 UBIQUITIN LIGASE FOR DIO2, AND INTERACTION WITH DIO2.
RX   PubMed=19651899; DOI=10.1128/mcb.01498-08;
RA   Zavacki A.M., Arrojo E Drigo R., Freitas B.C., Chung M., Harney J.W.,
RA   Egri P., Wittmann G., Fekete C., Gereben B., Bianco A.C.;
RT   "The E3 ubiquitin ligase TEB4 mediates degradation of type 2 iodothyronine
RT   deiodinase.";
RL   Mol. Cell. Biol. 29:5339-5347(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH SQLE, MUTAGENESIS OF CYS-9,
RP   AND DOMAIN.
RX   PubMed=24449766; DOI=10.1128/mcb.01140-13;
RA   Zelcer N., Sharpe L.J., Loregger A., Kristiana I., Cook E.C., Phan L.,
RA   Stevenson J., Brown A.J.;
RT   "The E3 ubiquitin ligase MARCH6 degrades squalene monooxygenase and affects
RT   3-hydroxy-3-methyl-glutaryl coenzyme A reductase and the cholesterol
RT   synthesis pathway.";
RL   Mol. Cell. Biol. 34:1262-1270(2014).
RN   [13]
RP   INVOLVEMENT IN FAME3.
RX   PubMed=31664039; DOI=10.1038/s41467-019-12763-9;
RG   FAME consortium;
RA   Florian R.T., Kraft F., Leitao E., Kaya S., Klebe S., Magnin E.,
RA   van Rootselaar A.F., Buratti J., Kuehnel T., Schroeder C., Giesselmann S.,
RA   Tschernoster N., Altmueller J., Lamiral A., Keren B., Nava C.,
RA   Bouteiller D., Forlani S., Jornea L., Kubica R., Ye T., Plassard D.,
RA   Jost B., Meyer V., Deleuze J.F., Delpu Y., Avarello M.D.M.,
RA   Vijfhuizen L.S., Rudolf G., Hirsch E., Kroes T., Reif P.S., Rosenow F.,
RA   Ganos C., Vidailhet M., Thivard L., Mathieu A., Bourgeron T., Kurth I.,
RA   Rafehi H., Steenpass L., Horsthemke B., LeGuern E., Klein K.M., Labauge P.,
RA   Bennett M.F., Bahlo M., Gecz J., Corbett M.A., Tijssen M.A.J.,
RA   van den Maagdenberg A.M.J.M., Depienne C.;
RT   "Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial
RT   Adult Myoclonic Epilepsy type 3.";
RL   Nat. Commun. 10:4919-4919(2019).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that promotes 'Lys-48'-linked
CC       ubiquitination of target proteins, leading to their proteasomal
CC       degradation (PubMed:15673284). Promotes ubiquitination of DIO2, leading
CC       to its degradation (PubMed:19651899). Promotes ubiquitination of SQLE,
CC       leading to its degradation (PubMed:24449766). E3 ubiquitin ligases
CC       accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of
CC       a thioester and then directly transfer the ubiquitin to targeted
CC       substrates. May cooperate with UBE2G1 (PubMed:15673284).
CC       {ECO:0000269|PubMed:15673284, ECO:0000269|PubMed:19651899,
CC       ECO:0000269|PubMed:24449766}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:15673284};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:15673284}.
CC   -!- SUBUNIT: Interacts with DIO2 (PubMed:19651899). Interacts with SQLE
CC       (PubMed:24449766). {ECO:0000269|PubMed:19651899,
CC       ECO:0000269|PubMed:24449766}.
CC   -!- INTERACTION:
CC       O60337; Q9UHX3: ADGRE2; NbExp=3; IntAct=EBI-2684600, EBI-11277970;
CC       O60337; P41220-1: RGS2; NbExp=3; IntAct=EBI-2684600, EBI-16037474;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:15673284}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15673284}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O60337-4; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60337-5; Sequence=VSP_047036;
CC       Name=3;
CC         IsoId=O60337-6; Sequence=VSP_047035;
CC   -!- TISSUE SPECIFICITY: Present in brain (at protein level).
CC       {ECO:0000269|PubMed:15673284}.
CC   -!- DOMAIN: The RING-CH-type zinc finger domain is required for E3 ligase
CC       activity. {ECO:0000269|PubMed:15673284, ECO:0000269|PubMed:24449766}.
CC   -!- PTM: Auto-ubiquitinated, which results in proteasomal degradation.
CC       {ECO:0000269|PubMed:15673284}.
CC   -!- DISEASE: Epilepsy, familial adult myoclonic, 3 (FAME3) [MIM:613608]: A
CC       form of familial myoclonic epilepsy, a neurologic disorder
CC       characterized by cortical hand tremors, myoclonic jerks and occasional
CC       generalized or focal seizures with a non-progressive or very slowly
CC       progressive disease course. Usually, myoclonic tremor is the presenting
CC       symptom, characterized by tremulous finger movements and myoclonic
CC       jerks of the limbs increased by action and posture. In a minority of
CC       patients, seizures are the presenting symptom. Some patients exhibit
CC       mild cognitive impairment. FAME3 inheritance is autosomal dominant.
CC       {ECO:0000269|PubMed:31664039}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB66840.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAB66840.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAA25523.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB011169; BAA25523.1; ALT_INIT; mRNA.
DR   EMBL; AK296585; BAG59204.1; -; mRNA.
DR   EMBL; AK300034; BAG61845.1; -; mRNA.
DR   EMBL; AC012640; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092336; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471102; EAX08065.1; -; Genomic_DNA.
DR   EMBL; CH471102; EAX08066.1; -; Genomic_DNA.
DR   EMBL; BC046148; AAH46148.1; -; mRNA.
DR   EMBL; BC136461; AAI36462.1; -; mRNA.
DR   EMBL; BC136462; AAI36463.1; -; mRNA.
DR   EMBL; BC142679; AAI42680.1; -; mRNA.
DR   EMBL; BC142694; AAI42695.1; -; mRNA.
DR   EMBL; AF009301; AAB66840.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS34135.1; -. [O60337-4]
DR   CCDS; CCDS59487.1; -. [O60337-5]
DR   CCDS; CCDS59488.1; -. [O60337-6]
DR   PIR; T00268; T00268.
DR   RefSeq; NP_001257589.1; NM_001270660.1. [O60337-5]
DR   RefSeq; NP_001257590.1; NM_001270661.1. [O60337-6]
DR   RefSeq; NP_005876.2; NM_005885.3. [O60337-4]
DR   AlphaFoldDB; O60337; -.
DR   SMR; O60337; -.
DR   BioGRID; 115587; 57.
DR   DIP; DIP-56134N; -.
DR   IntAct; O60337; 19.
DR   MINT; O60337; -.
DR   STRING; 9606.ENSP00000274140; -.
DR   iPTMnet; O60337; -.
DR   PhosphoSitePlus; O60337; -.
DR   SwissPalm; O60337; -.
DR   BioMuta; MARCH6; -.
DR   EPD; O60337; -.
DR   jPOST; O60337; -.
DR   MassIVE; O60337; -.
DR   MaxQB; O60337; -.
DR   PaxDb; O60337; -.
DR   PeptideAtlas; O60337; -.
DR   ProteomicsDB; 4463; -.
DR   ProteomicsDB; 49363; -. [O60337-4]
DR   ProteomicsDB; 5070; -.
DR   Antibodypedia; 22463; 175 antibodies from 29 providers.
DR   DNASU; 10299; -.
DR   Ensembl; ENST00000274140.10; ENSP00000274140.4; ENSG00000145495.16. [O60337-4]
DR   Ensembl; ENST00000449913.6; ENSP00000414643.2; ENSG00000145495.16. [O60337-5]
DR   Ensembl; ENST00000503788.5; ENSP00000425930.1; ENSG00000145495.16. [O60337-6]
DR   GeneID; 10299; -.
DR   KEGG; hsa:10299; -.
DR   MANE-Select; ENST00000274140.10; ENSP00000274140.4; NM_005885.4; NP_005876.2.
DR   UCSC; uc003jet.3; human. [O60337-4]
DR   AGR; HGNC:30550; -.
DR   CTD; 10299; -.
DR   DisGeNET; 10299; -.
DR   GeneCards; MARCHF6; -.
DR   HGNC; HGNC:30550; MARCHF6.
DR   HPA; ENSG00000145495; Low tissue specificity.
DR   MalaCards; MARCHF6; -.
DR   MIM; 613297; gene.
DR   MIM; 613608; phenotype.
DR   neXtProt; NX_O60337; -.
DR   OpenTargets; ENSG00000145495; -.
DR   Orphanet; 86814; Benign adult familial myoclonic epilepsy.
DR   VEuPathDB; HostDB:ENSG00000145495; -.
DR   eggNOG; KOG1609; Eukaryota.
DR   GeneTree; ENSGT00940000155171; -.
DR   HOGENOM; CLU_006373_1_0_1; -.
DR   InParanoid; O60337; -.
DR   OMA; WLHYSLV; -.
DR   OrthoDB; 1342875at2759; -.
DR   PhylomeDB; O60337; -.
DR   TreeFam; TF105777; -.
DR   BioCyc; MetaCyc:ENSG00000145495-MON; -.
DR   BRENDA; 2.3.2.27; 2681.
DR   PathwayCommons; O60337; -.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   SignaLink; O60337; -.
DR   SIGNOR; O60337; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 10299; 39 hits in 1127 CRISPR screens.
DR   ChiTaRS; MARCH6; human.
DR   GeneWiki; MARCH6; -.
DR   GenomeRNAi; 10299; -.
DR   Pharos; O60337; Tbio.
DR   PRO; PR:O60337; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; O60337; protein.
DR   Bgee; ENSG00000145495; Expressed in Brodmann (1909) area 23 and 208 other tissues.
DR   ExpressionAtlas; O60337; baseline and differential.
DR   Genevisible; O60337; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0044322; C:endoplasmic reticulum quality control compartment; IEA:GOC.
DR   GO; GO:0000835; C:ER ubiquitin ligase complex; IC:ParkinsonsUK-UCL.
DR   GO; GO:0016020; C:membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IPI:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:1990381; F:ubiquitin-specific protease binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:1904380; P:endoplasmic reticulum mannose trimming; TAS:Reactome.
DR   GO; GO:0036503; P:ERAD pathway; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0010498; P:proteasomal protein catabolic process; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IBA:GO_Central.
DR   CDD; cd16702; RING_CH-C4HC3_MARCH6; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR011016; Znf_RING-CH.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR13145:SF0; E3 UBIQUITIN-PROTEIN LIGASE MARCHF6; 1.
DR   PANTHER; PTHR13145; SSM4 PROTEIN; 1.
DR   Pfam; PF12906; RINGv; 1.
DR   SMART; SM00744; RINGv; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS51292; ZF_RING_CH; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Endoplasmic reticulum; Epilepsy;
KW   Membrane; Metal-binding; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix; Ubl conjugation; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..910
FT                   /note="E3 ubiquitin-protein ligase MARCHF6"
FT                   /id="PRO_0000274298"
FT   TOPO_DOM        1..91
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:15673284,
FT                   ECO:0000305|PubMed:16373356"
FT   TRANSMEM        92..112
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        113..142
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        143..163
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        164..283
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        284..304
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        305..336
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        337..357
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        358..376
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        377..397
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        398..421
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        422..442
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        443..480
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        481..501
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        502..519
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        520..540
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        541..632
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        633..653
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        654..678
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        679..699
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        700..721
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        722..742
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        743..764
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        765..785
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        786..815
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        816..836
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        837..848
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        849..869
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        870..910
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:16373356"
FT   ZN_FING         1..62
FT                   /note="RING-CH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   REGION          185..256
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        224..246
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         9
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         12
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         26
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         28
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         36
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         39
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         52
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         55
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   VAR_SEQ         7..112
FT                   /note="DICRVCRSEGTPEKPLYHPCVCTGSIKFIHQECLVQWLKHSRKEYCELCKHR
FT                   FAFTPIYSPDMPSRLPIQDIFAGLVTSIGTAIRYWFHYTLVAFAWLGVVPLTAC -> G
FT                   (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047035"
FT   VAR_SEQ         64..112
FT                   /note="IYSPDMPSRLPIQDIFAGLVTSIGTAIRYWFHYTLVAFAWLGVVPLTAC ->
FT                   S (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047036"
FT   VARIANT         622
FT                   /note="P -> L (in dbSNP:rs1062914)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_030251"
FT   MUTAGEN         9
FT                   /note="C->A: Abolishes auto-ubiquitination. Loss of
FT                   ubiquitin ligase activity."
FT                   /evidence="ECO:0000269|PubMed:15673284,
FT                   ECO:0000269|PubMed:24449766"
FT   CONFLICT        380
FT                   /note="V -> VG (in Ref. 6; AAB66840)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        384
FT                   /note="G -> GS (in Ref. 6; AAB66840)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        390
FT                   /note="C -> WW (in Ref. 6; AAB66840)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        395
FT                   /note="D -> G (in Ref. 6; AAB66840)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        399
FT                   /note="L -> LG (in Ref. 6; AAB66840)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        546
FT                   /note="R -> K (in Ref. 6; AAB66840)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   910 AA;  102545 MW;  C7A96FEA45B5CA8D CRC64;
     MDTAEEDICR VCRSEGTPEK PLYHPCVCTG SIKFIHQECL VQWLKHSRKE YCELCKHRFA
     FTPIYSPDMP SRLPIQDIFA GLVTSIGTAI RYWFHYTLVA FAWLGVVPLT ACRIYKCLFT
     GSVSSLLTLP LDMLSTENLL ADCLQGCFVV TCTLCAFISL VWLREQIVHG GAPIWLEHAA
     PPFNAAGHHQ NEAPAGGNGA ENVAADQPAN PPAENAVVGE NPDAQDDQAE EEEEDNEEED
     DAGVEDAADA NNGAQDDMNW NALEWDRAAE ELTWERMLGL DGSLVFLEHV FWVVSLNTLF
     ILVFAFCPYH IGHFSLVGLG FEEHVQASHF EGLITTIVGY ILLAITLIIC HGLATLVKFH
     RSRRLLGVCY IVVKVSLLVV VEIGVFPLIC GWWLDICSLE MFDATLKDRE LSFQSAPGTT
     MFLHWLVGMV YVFYFASFIL LLREVLRPGV LWFLRNLNDP DFNPVQEMIH LPIYRHLRRF
     ILSVIVFGSI VLLMLWLPIR IIKSVLPNFL PYNVMLYSDA PVSELSLELL LLQVVLPALL
     EQGHTRQWLK GLVRAWTVTA GYLLDLHSYL LGDQEENENS ANQQVNNNQH ARNNNAIPVV
     GEGLHAAHQA ILQQGGPVGF QPYRRPLNFP LRIFLLIVFM CITLLIASLI CLTLPVFAGR
     WLMSFWTGTA KIHELYTAAC GLYVCWLTIR AVTVMVAWMP QGRRVIFQKV KEWSLMIMKT
     LIVAVLLAGV VPLLLGLLFE LVIVAPLRVP LDQTPLFYPW QDWALGVLHA KIIAAITLMG
     PQWWLKTVIE QVYANGIRNI DLHYIVRKLA APVISVLLLS LCVPYVIASG VVPLLGVTAE
     MQNLVHRRIY PFLLMVVVLM AILSFQVRQF KRLYEHIKND KYLVGQRLVN YERKSGKQGS
     SPPPPQSSQE
//
